Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-11-01
1991-03-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 435 725, 435 29, 435184, A61K 3738, A61K 3743
Patent
active
049978152
ABSTRACT:
A method is provided for inhibiting the .gamma.-globin to .beta.-globin switching in subjects afflicted with .beta.-globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle cell disease or .beta.-thalassemias by periodically introducing into the subject prio r to natural completion of the switching process activin, inhibin, an inhibin chain or mixtures thereof.
REFERENCES:
patent: 4740587 (1988-04-01), Ling et al.
patent: 4822821 (1989-04-01), Perrine
Kerlsson, Annual Review, Biochem. 54, 1071-108 (1985).
Schechter, INSERM Symposium No. 9, Rosa, Q., et al. (1979), Elsevier, pp. 129-137.
Perrine et al, Biochem. Biophys. Research Comm., 148, 694 (1987).
Noguchi, et al., New England J. Med., Jan. 14, 1988, 96-99.
Wood, et al., British J. of Hematotogy45, 431-445 (1980).
Perrine et al., Abstract, The American Society of Hemotology 28th Annual Mtg. (1986), "The Physiologic Metabolite Inhibits Fetal Hemoglobin Switching in Erythroid Progenitors of Neonates and HBSS Infants."
Marata et al., PNAS USA 85, 2434-2438 (1988).
Tsuji et al., Biotechnology and Bioengineering 31, 675-681 (1988).
Marata et al., Biochem. and Biophys. Research Comm. 151, No. 1, 230-235 (1988).
Shibata, et al., Biochem. & Biophys. Research Comm. 146, No. 1, 1987 (1987).
Yu, et al., Nature, 330, 24/31, 765-767 (Dec. 1987).
Eto, Biochem & Biophys. Research Comm. 142, No. 3, 1095-1103 (1987).
Albers Norbert
Perrine Susan P.
Children's Hospital Medical Center of Northern California
Koh Choon P.
Regents of the University of California
Schain Howard E.
LandOfFree
Method for augmenting fetal hemoglobin by treatment with activin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for augmenting fetal hemoglobin by treatment with activin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for augmenting fetal hemoglobin by treatment with activin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-496812